Researchers discover a cause of neuron excitability in ALS, suggesting a new potential treatment
Researchers at Northwestern Medicine have identified that the protein TDP-43 causes neuron hyperexcitability in ALS patients by disrupting ion channels. The team has designed a potential drug to address this mechanism, offering a new path for treating the disease.
Why it matters
This discovery provides a specific molecular target for ALS treatment, which could significantly improve therapeutic outcomes for a currently incurable condition.
edited by Sadie Harley , reviewed by Robert Egan
The report focuses on scientific findings and medical research without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in